Testosterone Science

Media Watch

Is Testosterone the New Performance Hack for Executives?

Specific Claim Evaluated

Testosterone declines by about 1% a year on average, testosterone can suppress sperm production and men may receive unnecessary prescriptions after online blood tests; lifestyle factors should be addressed before treatment.

Primary Research Supporting or Contradicting the Claim

Cohort data show an age-related decline of about 1% per year (Travison et al., 2007), and guidelines require symptoms and repeated morning testing before diagnosis (Bhasin et al., 2018).

Corrected Evidence-Based Interpretation

The article is correct. Testosterone therapy has no demonstrated benefit for work performance in men without hypogonadism.

Rationale for Grade

The article frames testosterone as a treatment for deficiency, cautions against self-diagnosis and states fertility and prostate risks accurately. It does not claim a performance benefit in men with normal testosterone.

References

  1. Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, Snyder PJ, Swerdloff RS, Wu FC, Yialamas MA. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. PMID
    Supporting excerpt: "We recommend making a diagnosis of hypogonadism only in men with symptoms and signs"
  2. Travison TG, Araujo AB, O'Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92(1):196-202. PMID
    Supporting excerpt: "a substantial, and as yet unrecognized, age-independent population-level decrease in T"

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.